The Latest Cardiac and Vascular News
CHICAGO–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive arrhythmia analysis and localization, announced today the presentation of new data showcasing the significant capabilities of vMap, its AI-powered solution for enhancing cardiac arrhythmia treatment. To be presented on November 17 at the American Heart Association (AHA) Scientific Sessions 2024, this data highlights vMap’s impressive 91.1% accuracy rate […]
September 06, 2024 07:59 AM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will present findings today at HRX 2024. The two studies showcase how Vektor’s advanced technologies uniquely leverage AI and deep learning to assess wall thickness and scar tissue in ventricular tachycardia (VT) patients, providing crucial insights […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today unveiled a comprehensive schedule of educational content and sessions featuring the use of vMap® at this year’s Heart Rhythm 2024 conference in Boston, May 16-19. vMap rapidly provides actionable arrhythmia localization insights for physicians. The research and presentations at HRS further demonstrate the unique ability […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced the publication of data in the Journal of Cardiovascular Electrophysiology (JACE) demonstrating vMap’s ability to reduce the time from mapping to treatment, procedure duration, and fluoroscopy when treating cardiac arrhythmia patients with ablation therapy. “A 22.6% reduction in procedure duration is significant” Post […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care. “The medical community is being confronted with […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in arrhythmia care and developer of the only FDA-cleared non-invasive technology to accurately map arrhythmias using just 12-lead ECG data, is delighted to announce the expansion of its esteemed Medical Advisory Board. The newly expanded Medical Advisory Board, features preeminent electrophysiology leaders, including: Dr. John Miller at Indiana University Health […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ECG data, today announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap. Designed to improve ablation outcomes and procedural efficiencies, the newly updated vMap software integrates additional automation and advanced visualization features. vMap […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the vMap® next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor’s advisory board. With more than two decades of […]
Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today announced that use of the […]
Case studies highlighting vMap’s effectiveness at localizing arrhythmia termination sites in complex cases to be presented alongside vMap time study NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, developer of vMap® — the world’s first FDA-cleared technology to localize arrhythmias from just 12-lead ECG data — will present complex case studies that expand vMap’s utility at the Annual American College […]
